Michka
Yes! The Institut Gustave Roussy signed a license agreement with ExonHit a few years ago for a novel breast cancer "diagnostic" assay. The "diagnostic" value of this new signature allows for the discrimination between malignant tumors and benign lesions from cells sampled through find-needle aspiration.
And they are using cell-death assays for "drug discovery." It may be helpful to use a form of chemosensitivity testing, which is based upon the measurement of actual cancer cell death. The results of cell death endpoints (point of termination) agree with each other pretty well with hematologic and lymphatic neoplasms (non-solid cancers).
As for using cell-death assays for "drug selection," here is a contact email for Dr. Andrew Bosanquet, Bath. Dr. Bosanquet has a list of labs in Europe.
agb.scientist@gmail.com
Here is a contact email for Dr. Ian Cree, Queen Alexandra Hospital. He does the ATP cell-death assay.
ian.cree@porthosp.nhs.uk
You can also ship tumor specimens via FedEx or World Courier to any of the labs in the United States.
Best of luck on your endeavors!
Greg